Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/57469
Title: Virtual reality for COPD exacerbation: A randomized controlled trial
Authors: Kizmaz, E.
Telli, Atalay, O.
Çetin, N.
Uğurlu, E.
Keywords: COPD
Exacerbation
Pulmonary rehabilitation
Virtual reality
C reactive protein
adult
anxiety
anxiety disorder
Article
chronic obstructive lung disease
controlled study
COPD assessment test
cycling
daily life activity
depression
disease exacerbation
dyspnea
exercise
female
forced expiratory volume
forced vital capacity
functional status
Hospital Anxiety and Depression Scale
hospitalization
human
leisure
major clinical study
male
middle aged
neurorehabilitation
protein blood level
pulmonary rehabilitation
randomized controlled trial
self care
single blind procedure
sit-to-stand test
virtual reality
aged
anxiety
disease exacerbation
etiology
kinesiotherapy
pathophysiology
procedures
psychology
rehabilitation
therapy
treatment outcome
Activities of Daily Living
Aged
Anxiety
Depression
Disease Progression
Dyspnea
Exercise Therapy
Female
Humans
Male
Middle Aged
Pulmonary Disease, Chronic Obstructive
Treatment Outcome
Virtual Reality
Publisher: W.B. Saunders Ltd
Abstract: Background: Pulmonary rehabilitation (PR) is an effective treatment method for chronic obstructive pulmonary disease (COPD). However, individuals with chronic diseases that require lifelong treatment and experience exacerbations need motivational methods. Objectives: The aim of this study was to examine the effects of virtual reality on symptoms, daily living activity, functional capacity, anxiety and depression levels in COPD exacerbation. Methods: Fifty patients hospitalized for COPD exacerbation were included in the study. They were randomly assigned to two groups. Twenty-five patients participated in a traditional PR (once-daily until discharge), including pedaling exercises. The second/25 patients followed the same protocol but experienced cycling simulation in the forest via virtual reality (VR + PR). All patients were evaluated using 1-minute/Sit-to-Stand test (STST), modified-Medical Research Council (mMRC) scale, COPD Assessment test (CAT), Hospital Anxiety and Depression Scale (HADS), and London Chest Activities of Daily Living (LCADL) before and after the treatment. Results: The STST showed an increase in both groups post-treatment, notably higher in the VR + PR (p = 0.037). Dyspnea levels and CAT scores decreased in all patients, but the decrease was greater in the PR + VR group for both parameters (p = 0.062, p = 0.003; respectively). Both groups experienced a reduction in the HADS scores compared to the pre-treatment, with a more significant decrease in depression and the total score in the VR + PR (p < 0.05). LCADL's sub-parameters and total score, excluding household, decreased in both groups after treatment (p < 0.05). The improvement was more substantial in the VR + PR. Conclusions: Virtual reality provides benefits in the management of COPD exacerbations and can be used safely. Clinical trial registiration: Registered at clinicaltrials.gov, registration ID: NCT05687396, URL: www.clinicaltrials.gov. © 2024 Elsevier Ltd
URI: https://doi.org/10.1016/j.rmed.2024.107696
https://hdl.handle.net/11499/57469
ISSN: 0954-6111
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection

Show full item record



CORE Recommender

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.